Carla Fabrine Carvalho

Carla Fabrine Carvalho

Auto-generated profile, based on publicly available information

Carla Fabrine Carvalho

State University of Campinas, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
CCCarla Fabrine Carvalho
Carla Fabrine Carvalho
JTJulio Cesar Teixeira
Julio Cesar Teixeira
JBJoana Froes Bragança
Joana Froes Bragança
SDSophie Françoise Mauricette Derchain
Sophie Françoise Mauricette Derchain
LZLuiz Carlos Zeferino
Luiz Carlos Zeferino
DVDiama Bhadra Vale
Diama Bhadra Vale
The present update is a reassessment of the 2018 ‘Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil’ (Zeferino et al.)9, according to the changes observed in new international guidelines and knowledge updates. The most relevant and recent guidelines were assessed. Questions regarding the clinical practice were formulated, and the answers considered the perspective of the public and private sectors of the Brazilian health system. The review addressed risk-based strategies regarding age to start and stop screening, the use of cytology and colposcopy to support management decisions, treatment, follow-up strategies, and screening in specific groups, including vaccinated women. The update aims to improve the prevention of cervical cancer and to reduce overtreatment and the misuse of HPV testing.

21 September 2022 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
CCCarla Fabrine Carvalho
Carla Fabrine Carvalho
LCLarissa Bastos Eloy Costa
Larissa Bastos Eloy Costa
NSNatasha Caroline Sanches
Natasha Caroline Sanches
IDIngrid Iara Damas
Ingrid Iara Damas
LALiliana Aparecida Lucci De Angelo Andrade
Liliana Aparecida Lucci De Angelo Andrade
DVDiama Bhadra Vale
Diama Bhadra Vale

1 January 2025 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
MRMayana R.S. Ribeiro
Mayana R.S. Ribeiro
CCCarla Fabrine Carvalho
Carla Fabrine Carvalho
MGMaria Gomes
Maria Gomes
Geovanni Dantas CassaliGeovanni Dantas Cassali
Geovanni Dantas Cassali
DODirce R. Oliveira
Dirce R. Oliveira
The purpose of this study is to evaluate the effects of fructooligosaccharide (FOS) supplementation on the prevention of experimental giardiasis by analyzing morphological, biochemical, and parasitological parameters in a gerbil model. Gerbils were divided into four groups: uninfected control (CT), infected control (CTIN), uninfected and FOS-treated (FOS), and infected and FOS-treated (FOSIN). The FOS and FOSIN groups received 250 mg/day of FOS by gavage for 14 days. After this period, the CTIN and FOSIN groups were inoculated by gavage with 1 x 106 trophozoites/ml of Giardia lamblia. Fourteen days post-infection, all animals were euthanized, and blood, liver, small intestine, and feces were collected for analysis. FOS supplementation resulted in a 77% reduction in parasitic load. Additionally, FOS reduced infection-induced damage by preserving intestinal structure, improving metabolic parameters, and reducing hepatic oxidative stress. FOS was also effective in mitigating the effects of an established G. lamblia infection. These preliminary findings suggest that FOS has beneficial effects in the preventive treatment of Giardia lamblia infection.